Eli Lilly's lead in the obesity race has grown. Its recent stock performance says otherwise
Eli Lilly has been one of the worst-performing Club stocks over the past six months.
FrankLin
0
11
An Eli Lilly & Co. Zepbound injection pen, March 28, 2024.
Bloomberg | Bloomberg | Getty Images
Eli Lilly investors have received some really good news in recent months with a notable exception of how the stock has performed.
